InMed Pharmaceuticals, Inc.

InMed Pharmaceuticals, Inc.https://investorshangout.com/InMed-Pharmaceuticals-Inc-INM-90324/en-usThu, 03 Sep 2026 13:56:04 GMTCopyright InvestorsHangout.comNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Positive Preclinical Resultshttps://investorshangout.com/post/view?id=6772226https://investorshangout.com/post/view?id=6772226Tue, 24 Jun 2025 20:18:14 GMTNetworkNewsWire: InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-901: A Promising New Candidate for Alzheimer’s Thehttps://investorshangout.com/post/view?id=6716094https://investorshangout.com/post/view?id=6716094Thu, 29 Aug 2024 20:50:19 GMTNetworkNewsWire: InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer’s Drughttps://investorshangout.com/post/view?id=6715539https://investorshangout.com/post/view?id=6715539Mon, 26 Aug 2024 21:10:00 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Three U.S. Patent Issuancehttps://investorshangout.com/post/view?id=6714639https://investorshangout.com/post/view?id=6714639Wed, 21 Aug 2024 20:05:14 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Exciting INM-901 Data Provhttps://investorshangout.com/post/view?id=6714428https://investorshangout.com/post/view?id=6714428Tue, 20 Aug 2024 20:21:04 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089 Showing Great Promise in Thttps://investorshangout.com/post/view?id=6713752https://investorshangout.com/post/view?id=6713752Fri, 16 Aug 2024 19:51:14 GMTNetworkNewsWire: InMed Pharmaceuticals Inc. (NASDAQ: INM) Subsidiary BayMedica Releases Market Report for 2023 on https://investorshangout.com/post/view?id=6710909https://investorshangout.com/post/view?id=6710909Wed, 07 Aug 2024 20:59:53 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Long-Term Study Results Confhttps://investorshangout.com/post/view?id=6709594https://investorshangout.com/post/view?id=6709594Tue, 30 Jul 2024 20:56:05 GMTNetworkNewsWire: InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089, a Promising Treatment for Age-Related Macularhttps://investorshangout.com/post/view?id=6708510https://investorshangout.com/post/view?id=6708510Wed, 24 Jul 2024 20:11:37 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Significant Improvements frohttps://investorshangout.com/post/view?id=6706178https://investorshangout.com/post/view?id=6706178Thu, 11 Jul 2024 20:58:03 GMTNetworkNewsWire: InMed Pharmaceuticals Inc. (NASDAQ: INM) Advances Therapies Targeting Neurodegenerative Diseaseshttps://investorshangout.com/post/view?id=6701033https://investorshangout.com/post/view?id=6701033Fri, 14 Jun 2024 20:51:47 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation at Upcoming https://investorshangout.com/post/view?id=6700124https://investorshangout.com/post/view?id=6700124Tue, 11 Jun 2024 21:21:19 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q3 Fiscal 2024 Financial Rehttps://investorshangout.com/post/view?id=6693637https://investorshangout.com/post/view?id=6693637Tue, 14 May 2024 20:52:08 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Welcomes Leading Authority in Alzheihttps://investorshangout.com/post/view?id=6686077https://investorshangout.com/post/view?id=6686077Thu, 18 Apr 2024 19:49:21 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports on Promising Results from Sthttps://investorshangout.com/post/view?id=6685296https://investorshangout.com/post/view?id=6685296Tue, 16 Apr 2024 20:04:20 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Favorable Results from INM-https://investorshangout.com/post/view?id=6682392https://investorshangout.com/post/view?id=6682392Thu, 04 Apr 2024 20:32:07 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Receives Notification from NASDAQ ofhttps://investorshangout.com/post/view?id=6679467https://investorshangout.com/post/view?id=6679467Thu, 21 Mar 2024 21:01:32 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Financial Numbers for Q2 20https://investorshangout.com/post/view?id=6671400https://investorshangout.com/post/view?id=6671400Wed, 14 Feb 2024 21:05:39 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Names New Chief Financial Officerhttps://investorshangout.com/post/view?id=6670368https://investorshangout.com/post/view?id=6670368Fri, 09 Feb 2024 22:09:33 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) CEO to Present at January Water Towehttps://investorshangout.com/post/view?id=6664863https://investorshangout.com/post/view?id=6664863Fri, 19 Jan 2024 20:58:51 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Business Update, Milestonehttps://investorshangout.com/post/view?id=6663635https://investorshangout.com/post/view?id=6663635Tue, 16 Jan 2024 21:13:33 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Approves Election of Directors Durinhttps://investorshangout.com/post/view?id=6655948https://investorshangout.com/post/view?id=6655948Wed, 20 Dec 2023 20:54:38 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q1 Fiscal 2024 Financial Rhttps://investorshangout.com/post/view?id=6643954https://investorshangout.com/post/view?id=6643954Tue, 14 Nov 2023 20:20:47 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present Phase 2 Study Results forhttps://investorshangout.com/post/view?id=6640235https://investorshangout.com/post/view?id=6640235Thu, 02 Nov 2023 20:36:37 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Secures $5.2M in Private Placement ahttps://investorshangout.com/post/view?id=6637987https://investorshangout.com/post/view?id=6637987Fri, 27 Oct 2023 21:48:52 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Enters Agreements for Private Placemhttps://investorshangout.com/post/view?id=6636875https://investorshangout.com/post/view?id=6636875Wed, 25 Oct 2023 21:04:48 GMTznewcar1: $INM 70% v102M c.9891 f3,328M Hod2.08 ML=LL.45 gapNcrap https://investorshangout.com/post/view?id=6636380https://investorshangout.com/post/view?id=6636380Wed, 25 Oct 2023 02:18:02 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Advance INM-901 Following Positivhttps://investorshangout.com/post/view?id=6636323https://investorshangout.com/post/view?id=6636323Tue, 24 Oct 2023 21:37:02 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases FY 2023 Report, Shares Corphttps://investorshangout.com/post/view?id=6624430https://investorshangout.com/post/view?id=6624430Fri, 29 Sep 2023 20:27:25 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Water Towhttps://investorshangout.com/post/view?id=6599118https://investorshangout.com/post/view?id=6599118Fri, 21 Jul 2023 20:03:06 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on BayMedica Rare Cannhttps://investorshangout.com/post/view?id=6598683https://investorshangout.com/post/view?id=6598683Thu, 20 Jul 2023 20:17:28 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) 755-201-EB Trial Demonstrates Clinhttps://investorshangout.com/post/view?id=6588698https://investorshangout.com/post/view?id=6588698Thu, 22 Jun 2023 20:15:41 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Sponsored Research Presented at Canahttps://investorshangout.com/post/view?id=6581434https://investorshangout.com/post/view?id=6581434Thu, 01 Jun 2023 19:48:42 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Plans to Participate in Vihttps://investorshangout.com/post/view?id=6579176https://investorshangout.com/post/view?id=6579176Thu, 25 May 2023 20:18:33 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) CEO Featured in Upcoming Water Towerhttps://investorshangout.com/post/view?id=6577120https://investorshangout.com/post/view?id=6577120Fri, 19 May 2023 20:19:33 GMTznewcar1: $INM 20% v575K c1.39 f3,328M H1.45 ML1.11https://investorshangout.com/post/view?id=6576720https://investorshangout.com/post/view?id=6576720Fri, 19 May 2023 01:53:27 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q3 2023 Financial Results,https://investorshangout.com/post/view?id=6575021https://investorshangout.com/post/view?id=6575021Mon, 15 May 2023 20:06:05 GMTznewcar1: $INM 38% v22,1M c1.46 f3,328M H1.68 ML.92https://investorshangout.com/post/view?id=6550639https://investorshangout.com/post/view?id=6550639Mon, 20 Mar 2023 22:43:43 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Peer-Reviewed Study Results Publishehttps://investorshangout.com/post/view?id=6547845https://investorshangout.com/post/view?id=6547845Mon, 13 Mar 2023 20:57:12 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q2 2023 Financial, Corporathttps://investorshangout.com/post/view?id=6539710https://investorshangout.com/post/view?id=6539710Tue, 21 Feb 2023 20:43:52 GMTznewcar1: $INM 36% v4,4M c2.30 f1,589M H2.41 ML1.23https://investorshangout.com/post/view?id=6521218https://investorshangout.com/post/view?id=6521218Tue, 10 Jan 2023 22:04:53 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Key Milestones, 2023 Businhttps://investorshangout.com/post/view?id=6521165https://investorshangout.com/post/view?id=6521165Tue, 10 Jan 2023 20:35:09 GMTznewcar1: $INM 27% v2,7M c2.02 f1,590M H2.39 ML1.23 YL1.34 with spikes th HHhttps://investorshangout.com/post/view?id=6517104https://investorshangout.com/post/view?id=6517104Fri, 30 Dec 2022 21:47:36 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Shares Annual General Meeting Resulthttps://investorshangout.com/post/view?id=6511963https://investorshangout.com/post/view?id=6511963Fri, 16 Dec 2022 20:48:30 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Appoints Interim Chief Financial Offhttps://investorshangout.com/post/view?id=6510609https://investorshangout.com/post/view?id=6510609Tue, 13 Dec 2022 21:09:44 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Close on $6M Private Placehttps://investorshangout.com/post/view?id=6502086https://investorshangout.com/post/view?id=6502086Tue, 22 Nov 2022 20:42:06 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Anticipated $6M Private Plhttps://investorshangout.com/post/view?id=6500654https://investorshangout.com/post/view?id=6500654Fri, 18 Nov 2022 20:53:02 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Accounting VP, Controllerhttps://investorshangout.com/post/view?id=6500000https://investorshangout.com/post/view?id=6500000Thu, 17 Nov 2022 21:14:03 GMTznewcar1: $INM 36% v28,3M c3.79 f936,761 H4.75 ML2.4 YL2.54https://investorshangout.com/post/view?id=6499377https://investorshangout.com/post/view?id=6499377Wed, 16 Nov 2022 21:15:06 GMTNetworkNewsWire: NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Gains Alliance Grant Funding, Launchhttps://investorshangout.com/post/view?id=6499348https://investorshangout.com/post/view?id=6499348Wed, 16 Nov 2022 20:38:49 GMT